pamidronate and penicillamine

pamidronate has been researched along with penicillamine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ceponis, A; Ding, Y; Konttinen, YT; Lindy, O; López-Otín, C; Santavirta, S; Sorsa, T	1
Akizawa, T; Koshikawa, S; Kuroki, A	1

Reviews

2 review(s) available for pamidronate and penicillamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Drug-induced nephrotic syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antineoplastic Agents; Antirheumatic Agents; Bone Density Conservation Agents; Cysteine; Diphosphonates; Gold Compounds; Humans; Interferons; Lithium Compounds; Nephrotic Syndrome; Pamidronate; Penicillamine	2007

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

[Drug-induced nephrotic syndrome].

Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antineoplastic Agents; Antirheumatic Agents; Bone Density Conservation Agents; Cysteine; Diphosphonates; Gold Compounds; Humans; Interferons; Lithium Compounds; Nephrotic Syndrome; Pamidronate; Penicillamine

2007

Other Studies

2 other study(ies) available for pamidronate and penicillamine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis and rheumatism, 1997, Volume: 40, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cartilage, Articular; Clodronic Acid; Collagenases; Diphosphonates; Female; Humans; Immunoblotting; Immunohistochemistry; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Middle Aged; Osteoarthritis; Pamidronate; Penicillamine; Recombinant Proteins; RNA, Messenger; Synovial Membrane	1997

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium.

Arthritis and rheumatism, 1997, Volume: 40, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cartilage, Articular; Clodronic Acid; Collagenases; Diphosphonates; Female; Humans; Immunoblotting; Immunohistochemistry; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Middle Aged; Osteoarthritis; Pamidronate; Penicillamine; Recombinant Proteins; RNA, Messenger; Synovial Membrane

1997